Malissa Wood, MD, associate chief of cardiology for diversity and equity at Massachusetts General Hospital, explains the role of health equity in cardiovascular care and what her health system is doing to address it. 

A new analysis reveals that insurers could put between $228 million and $2.15 billion back in taxpayers’ pockets by purchasing a series of generic oncology medications at the same prices obtained by the Mark Cuban Cost Plus Drug Company.

ACR, SIR, ASTRO and others are concerned about about forthcoming cuts in the Medicare Physician Fee Schedule that will impact specialties with high equipment costs.  

The device, now on display at TVT 2023 in Phoenix, is scheduled to begin hitting the market in the months ahead. 

SNMMI and ACR are pushing the agency to make modifications retroactive, so specialists can still claim lost revenues impacted by the error. 

“It is your firm’s responsibility to ensure compliance with applicable laws and regulations administered by FDA,” according to the warning letter. These issues, the agency added, “may be symptomatic of serious problems in your firm’s manufacturing and quality management systems.”

Avatar Medical said its VR solution can serve as an aid in pre-operative planning or for use during procedures. 

Merck believes the Inflation Reduction Act-launched effort “coerces” manufacturers to enter into agreements to sell their top products at a fraction of their actual value.